These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23428587)

  • 1. The beneficial impact of fasudil and sildenafil on monocrotaline-induced pulmonary hypertension in rats: a hemodynamic and biochemical study.
    Jasińska-Stroschein M; Owczarek J; Łuczak A; Orszulak-Michalak D
    Pharmacology; 2013; 91(3-4):178-84. PubMed ID: 23428587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil.
    Mouchaers KT; Schalij I; de Boer MA; Postmus PE; van Hinsbergh VW; van Nieuw Amerongen GP; Vonk Noordegraaf A; van der Laarse WJ
    Eur Respir J; 2010 Oct; 36(4):800-7. PubMed ID: 20351034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent rho-kinase and tyrosine kinase platelet-derived growth factor inhibition in experimental pulmonary hypertension.
    Jasińska-Stroschein M; Owczarek J; Plichta P; Orszulak-Michalak D
    Pharmacology; 2014; 93(3-4):145-50. PubMed ID: 24662671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hemodynamic response to acute combination and monotherapy with sildenafil and brain natriuretic peptide in rats with monocrotaline-induced pulmonary hypertension.
    Carlino C; Tobias JD; Schneider RI; Heller RL; Alpert MA; Grueber RE; Dellsperger KC; Demarco VG
    Am J Med Sci; 2010 Jan; 339(1):55-9. PubMed ID: 19996941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with fasudil and sildenafil ameliorates monocrotaline-induced pulmonary hypertension and survival in rats.
    Elias-Al-Mamun M; Satoh K; Tanaka S; Shimizu T; Nergui S; Miyata S; Fukumoto Y; Shimokawa H
    Circ J; 2014; 78(4):967-76. PubMed ID: 24553194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosuvastatin, sildenafil and their combination in monocrotaline-induced pulmonary hypertension in rat.
    Jasińska-Stroschein M; Owczarek J; Wesołowska A; Orszulak-Michalak D
    Acta Pharm; 2014 Sep; 64(3):345-53. PubMed ID: 25296680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
    Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
    Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sildenafil improves long-term effect of endothelial progenitor cell-based treatment for monocrotaline-induced rat pulmonary arterial hypertension.
    Yen CH; Tsai TH; Leu S; Chen YL; Chang LT; Chai HT; Chung SY; Chua S; Tsai CY; Chang HW; Ko SF; Sun CK; Yip HK
    Cytotherapy; 2013 Feb; 15(2):209-23. PubMed ID: 23321332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of everolimus in combination with sildenafil in monocrotaline-induced pulmonary hypertension in rats.
    Ilgin S; Burukoglu D; Atli O; Sirmagul B
    Cardiovasc Toxicol; 2012 Mar; 12(1):46-55. PubMed ID: 21811847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension.
    Gupta V; Gupta N; Shaik IH; Mehvar R; McMurtry IF; Oka M; Nozik-Grayck E; Komatsu M; Ahsan F
    J Control Release; 2013 Apr; 167(2):189-99. PubMed ID: 23353807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute vasodilator effect of fasudil, a Rho-kinase inhibitor, in monocrotaline-induced pulmonary hypertension in rats.
    Jiang BH; Tawara S; Abe K; Takaki A; Fukumoto Y; Shimokawa H
    J Cardiovasc Pharmacol; 2007 Feb; 49(2):85-9. PubMed ID: 17312448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocktail of Superoxide Dismutase and Fasudil Encapsulated in Targeted Liposomes Slows PAH Progression at a Reduced Dosing Frequency.
    Gupta N; Rashid J; Nozik-Grayck E; McMurtry IF; Stenmark KR; Ahsan F
    Mol Pharm; 2017 Mar; 14(3):830-841. PubMed ID: 28165252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
    Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
    Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bosentan, sildenafil, and their combination in the monocrotaline model of pulmonary hypertension in rats.
    Clozel M; Hess P; Rey M; Iglarz M; Binkert C; Qiu C
    Exp Biol Med (Maywood); 2006 Jun; 231(6):967-73. PubMed ID: 16741032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fasudil reverses monocrotaline-induced pulmonary hypertension in rats].
    Jiang H; Guan RJ; Wang HY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Mar; 41(3):239-44. PubMed ID: 23879951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of imatinib at a low dose and sildenafil on pulmonary hypertension in rats.
    Jasińska-Stroschein M; Owczarek J; Cicha K; Orszulak-Michalak D
    Pharmazie; 2015 Jul; 70(7):477-9. PubMed ID: 26373209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Single Drug and Combined Short-term Administration of Sildenafil, Pimobendan, and Nicorandil on Right Ventricular Function in Rats With Monocrotaline-induced Pulmonary Hypertension.
    Nakata TM; Tanaka R; Yoshiyuki R; Fukayama T; Goya S; Fukushima R
    J Cardiovasc Pharmacol; 2015 Jun; 65(6):640-8. PubMed ID: 25806612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the endothelial functions in monocrotaline-induced pulmonary hypertension.
    Sirmagul B; Ilgin S; Atli O; Usanmaz SE; Demirel-Yilmaz E
    Clin Exp Hypertens; 2013; 35(3):220-7. PubMed ID: 22967272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats.
    Itoh T; Nagaya N; Fujii T; Iwase T; Nakanishi N; Hamada K; Kangawa K; Kimura H
    Am J Respir Crit Care Med; 2004 Jan; 169(1):34-8. PubMed ID: 14525801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hemodynamic responses to brain natriuretic peptide and sildenafil in patients with pulmonary arterial hypertension.
    Klinger JR; Thaker S; Houtchens J; Preston IR; Hill NS; Farber HW
    Chest; 2006 Feb; 129(2):417-425. PubMed ID: 16478861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.